MOFs-based bioelectrodes used in electrochemical biosensorsa.
S. no. | MOF | Biological recognition element | Target analyte | LOD | Linear range | Reference |
---|---|---|---|---|---|---|
1 | Co-MOF, ZIF-67 | Cobalt oxide hollow nanododecahedra (Co3O4-HND) | Glucose | 0.58 μM | 2.0 μM to 6.06 mM | 88 |
2 | Cr-MOF (MIL-53-CrIII) | — | H2O2 | 3.52 μM | 25 to 500 μM | 89 |
3 | Cu-MOF | Hemin | H2O2 | 0.14 μM | 10 to 24 400 μM | 90 |
4 | Cu-MOF | GOx | Glucose | 14.77 μM | 44.9 μM to 4.0 mM and from 4.0 to 19 mM | 91 |
5 | Cu-MOF | Tyrosinase | BPA | 13 nmol l−1 | 5.0 × 10−8 to 3.0 × 10−6 mol l−1 | 92 |
6 | Cu-MOF | — | miRNA | 0.35 fM | 1.0 fM to 10 nM | 93 |
7 | Fe-MIL-88-NH2 | Hemin | ADRB1 gene | 0.21 fM | 1 fM to 10 nM | 46 |
8 | Fe-MOF | Pb2+-specific DNAzyme | Pb2+ | 2 pM | 0.005 to 1000 nmol L−1 | 94 |
9 | Ni-MOF | — | Urea | 3 μM | 0.01 to 1.12 mM | 95 |
10 | Ni-MOF | — | Glucose | 4.6 μM | 20 μM to 4.4 mM | 96 |
11 | Pb-BDC-NH2 and Cd-BDC-NH2 | anti-CEA | Carcinoembryonic antigen (CEA) | 0.03 pg mL−1 | 0.3 pg mL−1 to 3 ng mL−1 | 97 |
12 | Pb-BDC-NH2 and Cd-BDC-NH2 | anti-AFP | Alpha-fetoprotein (AFP) | 0.1 pg mL−1 | 0.3 pg mL−1 to 3 ng mL−1 | 97 |
13 | PCN-333(Al) | Microperoxidase-11 (MP-11) | H2O2 | 0.127 μM | 0.387 μM to 1.725 mM | 11 |
14 | Y-1, 4-NDC-MOF | AgNPs | H2O2 | 0.18 μM | 4 to 11 000 μM | 98 |
15 | Y-1, 4-NDC-MOF | CuNPs | H2O2 | 0.43 μM | 4 to 8500 μM | 98 |
16 | ZIF-67 | — | Glucose | 0.99 μM | 48 μm to 1 mM | 99 |
17 | ZIF-67 | — | Glucose | 0.66 μM | 2 to 1000 μM | 100 |
18 | ZIF-8 | HRP | H2O2 | 0–800 μM | 1 μM | 101 |
19 | ZIF-8 | LAC and GOx | Glucose | 5.347 μM | 1 to 10 mM | 42 |
20 | ZIF-8 | BPA | LAC | 5.347 μM | 1 to 20 mM | 41 |
GDH – glucose dehydrogenase, GOx – glucose oxidase, HRP – horseradish peroxidase, ADH – alcohol dehydrogenase, LAC – laccase, BPA – bisphenol A.